Decreased oligodendrocyte nuclear diameter in Alzheimer's disease and lewy body dementia

Brain Pathology

Volumn 22, Issue 6, 2012, Pages 803-810

  Gagyi, Eva ^a   Kormos, Bernadett ^a   Castellanos, Karla J ^a   Valyi Nagy, Klara ^a   Korneff, Dennis ^a   Lopresti, Patrizia ^a   Woltjer, Randy ^b   Valyi Nagy, Tibor ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; atrophy; Lewy body dementia; nuclear size; oligodendrocyte; white matter

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CELL NUCLEUS; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DIFFUSE LEWY BODY DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MORPHOMETRICS; NERVE CELL; OLIGODENDROGLIA; PARAHIPPOCAMPAL GYRUS; PYRAMIDAL NERVE CELL; TEMPORAL LOBE; TISSUE SECTION; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CELL NUCLEUS; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; OLIGODENDROGLIA;

EID: 84867571899     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00595.x     Document Type: Article

References (36)

1. Ball M, Braak H, Coleman P, Dickson D, Duyckaerts C, Gambietti P, et al, (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 (4 Suppl.): S1-S2.
2. Bartzokis G, (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25: 5-18.
3. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239-259.
4. Brun A, Englund E, (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253-262.
5. Bundgaard MJ, Regeur L, Gundersen HJ, Pakkenberg B, (2001) Size of neocortical neurons in control subjects and in Alzheimer's disease. J Anat 198: 481-489.
6. Bussière T, Giannakopoulos P, Bouras C, Perl DP, Morrison JH, Hof PR, (2003) Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J Comp Neurol 463: 281-302.
7. Cotman CW, Su JH, (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 6: 493-506.
8. Daniel B, DeCoster MA, (2004) Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain Res Brain Res Protoc 12: 144-150.
9. de la Monte SM, (1989) Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25: 450-459.
10. de Leeuw FE, Barkhof F, Scheltens P, (2004) White matter lesions and hippocampal atrophy in Alzheimer's disease. Neurology 62: 310-312.
11. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al, (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 106: 13010-13015.
12. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG, (1996) Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dementia 7: 304-313.
13. Duyckaerts C, Delatour B, Potier MC, (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol (Berl) 118: 5-36.
14. Everall IP, DeTeresa R, Terry R, Masliah E, (1997) Comparison of two quantitative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer disease. J Neuropathol Exp Neurol 56: 1202-1206.
15. Gong Y, Lippa CF, (2010) Disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Demen 25: 547-555.
16. Hanson JC, Lippa CF, (2009) Lewy body dementia. Int Rev Neurobiol 84: 215-228.
17. Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, et al, (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 1184: 284-294.
18. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al, (2010) Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (Berl) 119: 579-589.
19. Jacobs HI, Van Boxtel MP, Jolles J, Verhey FR, Uylings HB, (2012) Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings. Neurosci Biobehav Rev 36: 297-309.
20. Kobayashi K, Hayashi M, Nakano H, Fukutani Y, Sasaki K, Shimazaki M, Koshino Y, (2002) Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 28: 238-251.
21. Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH, (2010) A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25: 28-34.
22. Lee JT, Wheeler TC, Li L, Chin LS, (2008) Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum Mol Genet 17: 906-917.
23. Luckhaus C, (2009) Cerebral grey and white matter changes in mild cognitive impairment and Alzheimer's disease. Eur J Neurol 16: 438-439.
24. Mace PD, Riedl SJ, (2010) Molecular cell death platforms and assemblies. Curr Opin Cell Biol 22: 828-836.
25. Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P, (2001) Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol 49: 776-785.
26. Mann DM, Yates PO, Marcyniuk B, (1985) Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci 69: 139-159.
27. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al, (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872.
28. Nakamura T, Lipton SA, (2010) Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis 15: 1354-1363.
29. Okouchi M, Ekshyyan O, Maracine M, Aw TY, (2007) Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal 9: 1059-1096.
30. Regeur L, (1999) Increasing loss of brain tissue with increasing dementia: a stereological study of post-mortem brains from elderly females. Eur J Neurol 7: 47-54.
31. Rinne JO, Paljärvi L, Rinne UK, (1987) Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol Sci 79: 67-76.
32. Riudavets MA, Iacono D, Resnick SM, O'Brien R, Zonderman AB, Martin LJ, et al, (2007) Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging 28: 1484-1492.
33. Roth AD, Ramírez G, Alarcõn R, Von Bernhardi R, (2005) Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation. Biol Res 38: 381-387.
34. Uyama N, Uchihara T, Mochizuki Y, Nakamura A, Takahashi R, Mizutani T, (2009) Selective nuclear shrinkage of oligodendrocytes lacking glial cytoplasmic inclusions in multiple system atrophy: a 3-dimensional volumetric study. J Neuropathol Exp Neurol 68: 1084-1091.
35. Whitman GT, Cotman CW, (2004) Oligodendrocyte degeneration in AD. Neurobiol Aging 25: 33-36.
36. Wolswijk G, (2000) Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123 (Pt 1): 105-115.